Oppenheimer & Co’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $22.2M | Buy |
184,185
+19,723
| +12% | +$2.28M | 0.27% | 62 |
|
|
2025
Q4 | $17.3M | Buy |
164,462
+3,198
| +2% | +$300K | 0.25% | 80 |
|
|
2025
Q3 | $13.5M | Sell |
161,264
-4,674
| -3% | -$385K | 0.17% | 126 |
|
|
2025
Q2 | $13.1M | Sell |
165,938
-36,725
| -18% | -$2.92M | 0.17% | 123 |
|
|
2025
Q1 | $18.2M | Sell |
202,663
-665
| -0.3% | -$62.1K | 0.27% | 69 |
|
|
2024
Q4 | $20.2M | Sell |
203,328
-2,910
| -1% | -$300K | 0.3% | 60 |
|
|
2024
Q3 | $23.4M | Buy |
206,238
+6,503
| +3% | +$773K | 0.36% | 47 |
|
|
2024
Q2 | $24.7M | Buy |
199,735
+1,598
| +0.8% | +$206K | 0.39% | 41 |
|
|
2024
Q1 | $26.1M | Sell |
198,137
-138
| -0.1% | -$17K | 0.43% | 37 |
|
|
2023
Q4 | $21.6M | Sell |
198,275
-15,213
| -7% | -$1.58M | 0.4% | 42 |
|
|
2023
Q3 | $22M | Sell |
213,488
-52,377
| -20% | -$5.65M | 0.45% | 34 |
|
|
2023
Q2 | $30.7M | Sell |
265,865
-12,247
| -4% | -$1.39M | 0.61% | 17 |
|
|
2023
Q1 | $29.6M | Sell |
278,112
-10,914
| -4% | -$1.18M | 0.63% | 17 |
|
|
2022
Q4 | $32.1M | Sell |
289,026
-21,203
| -7% | -$2.17M | 0.73% | 15 |
|
|
2022
Q3 | $26.7M | Sell |
310,229
-10,079
| -3% | -$900K | 0.63% | 19 |
|
|
2022
Q2 | $29.2M | Buy |
320,308
+11,314
| +4% | +$1M | 0.63% | 16 |
|
|
2022
Q1 | $25.4M | Buy |
308,994
+16,668
| +6% | +$1.31M | 0.46% | 32 |
|
|
2021
Q4 | $22.4M | Buy |
292,326
+14,070
| +5% | +$1.12M | 0.39% | 44 |
|
|
2021
Q3 | $20.9M | Sell |
278,256
-5,916
| -2% | -$450K | 0.39% | 44 |
|
|
2021
Q2 | $22.1M | Buy |
284,172
+6,538
| +2% | +$486K | 0.4% | 42 |
|
|
2021
Q1 | $20.4M | Sell |
277,634
-2,946
| -1% | -$217K | 0.41% | 40 |
|
|
2020
Q4 | $21.9M | Sell |
280,580
-1,945
| -0.7% | -$149K | 0.46% | 38 |
|
|
2020
Q3 | $22.4M | Sell |
282,525
-5,560
| -2% | -$436K | 0.56% | 29 |
|
|
2020
Q2 | $21.3M | Sell |
288,085
-44,095
| -13% | -$3.32M | 0.55% | 35 |
|
|
2020
Q1 | $24.4M | Buy |
332,180
+33,374
| +11% | +$2.62M | 0.74% | 21 |
|
|
2019
Q4 | $25.9M | Sell |
298,806
-10,839
| -4% | -$890K | 0.64% | 26 |
|
|
2019
Q3 | $24.9M | Buy |
309,645
+1,650
| +0.5% | +$132K | 0.68% | 24 |
|
|
2019
Q2 | $24.6M | Sell |
307,995
-7,319
| -2% | -$560K | 0.67% | 25 |
|
|
2019
Q1 | $25M | Buy |
315,314
+8,359
| +3% | +$625K | 0.67% | 25 |
|
|
2018
Q4 | $22.4M | Sell |
306,955
-823
| -0.3% | -$58.1K | 0.7% | 26 |
|
|
2018
Q3 | $20.8M | Buy |
307,778
+9,369
| +3% | +$597K | 0.53% | 38 |
|
|
2018
Q2 | $17.3M | Buy |
298,409
+3,941
| +1% | +$222K | 0.47% | 44 |
|
|
2018
Q1 | $15.3M | Buy |
294,468
+16,114
| +6% | +$870K | 0.39% | 54 |
|
|
2017
Q4 | $14.9M | Sell |
278,354
-31,448
| -10% | -$1.74M | 0.38% | 56 |
|
|
2017
Q3 | $18.9M | Buy |
309,802
+9,919
| +3% | +$601K | 0.51% | 36 |
|
|
2017
Q2 | $18.3M | Sell |
299,883
-8,652
| -3% | -$527K | 0.51% | 33 |
|
|
2017
Q1 | $18.7M | Sell |
308,535
-1,348
| -0.4% | -$81.8K | 0.53% | 32 |
|
|
2016
Q4 | $17.4M | Sell |
309,883
-8,637
| -3% | -$505K | 0.51% | 37 |
|
|
2016
Q3 | $19M | Sell |
318,520
-37,241
| -10% | -$2.18M | 0.55% | 31 |
|
|
2016
Q2 | $19.6M | Sell |
355,761
-20,913
| -6% | -$1.11M | 0.58% | 24 |
|
|
2016
Q1 | $19M | Buy |
376,674
+1,092
| +0.3% | +$53.5K | 0.58% | 28 |
|
|
2015
Q4 | $18.9M | Buy |
375,582
+3,039
| +0.8% | +$153K | 0.56% | 31 |
|
|
2015
Q3 | $17.6M | Buy |
372,543
+21,800
| +6% | +$1.16M | 0.53% | 32 |
|
|
2015
Q2 | $19.1M | Sell |
350,743
-9,781
| -3% | -$549K | 0.53% | 31 |
|
|
2015
Q1 | $19.8M | Buy |
360,524
+11,979
| +3% | +$678K | 0.54% | 30 |
|
|
2014
Q4 | $18.9M | Sell |
348,545
-12,320
| -3% | -$686K | 0.54% | 32 |
|
|
2014
Q3 | $20.4M | Sell |
360,865
-41,968
| -10% | -$2.36M | 0.61% | 22 |
|
|
2014
Q2 | $22.2M | Sell |
402,833
-21,789
| -5% | -$1.19M | 0.67% | 21 |
|
|
2014
Q1 | $23M | Buy |
424,622
+29,810
| +8% | +$1.54M | 0.69% | 19 |
|
|
2013
Q4 | $18.9M | Sell |
394,812
-17,109
| -4% | -$782K | 0.6% | 23 |
|
|
2013
Q3 | $18.7M | Buy |
411,921
+64,131
| +18% | +$2.93M | 0.66% | 21 |
|
|
2013
Q2 | $15.4M | Buy |
+347,790
| New | +$15.5M | 0.6% | 25 |
|
Other funds holding MRK
VCM
VPM
Oppenheimer & Co's MRK Position: Q1 2026 in Review
Oppenheimer & Co increased its Merck (MRK) stake by 12% in Q1 2026, buying an estimated $2.28M and bringing the position to 184,185 shares worth $22.2M. The position accounts for 0.27% of the portfolio, ranked #62.
Oppenheimer & Co first reported a position in MRK in Q2 2013 and has held it in 52 quarters since. The position peaked at $32.1M in Q4 2022. 3,777 funds tracked by Wall St. Rank hold MRK as of Q1 2026.
- Oppenheimer & Co held 184,185 shares of Merck worth $22.2M as of Q1 2026.
- Oppenheimer & Co bought 19,723 Merck shares in Q1 2026, an estimated $2.28M.
- Merck made up 0.27% of Oppenheimer & Co's portfolio in Q1 2026, its #62 holding.
- Oppenheimer & Co first reported a position in Merck in Q2 2013 and has held it in 52 quarters since.
- Oppenheimer & Co's Merck position peaked at $32.1M in Q4 2022.
- 3,777 funds tracked by Wall St. Rank held Merck as of Q1 2026.
Based on Oppenheimer & Co's 13F filing for Q1 2026, filed 24 Apr 2026.